Top Big Cap Negative News Movers Premarket: CLDX: -8% Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab DGX: -6% Following new CMS Medicare payment talk on lab services ERIC: -4.5% Downgraded to UNDERWEIGHT @ MS